Basic Information
| RNALocate ID: | RLID:11000959 |
| RNA Symbol: | hsa-miR-93-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-93-5p |
| RNA ID: | miRBase:MIMAT0000093 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23382797 |
| Tissue/Cell Line: | Brain tissue |
| Method: | Microarray |
| Description: | We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001407 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01001408 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001409 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001410 | Mitochondrion | Myotube | 27396686 |
| RLID:01001411 | Mitochondrion | Skeletal muscle cells | 27563705 |
| RLID:01001412 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001413 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001414 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001415 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001416 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11000952 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11000953 | Exosome | Serum | 29143228 |
| RLID:11000954 | Exosome | Plasma | 30154547 |
| RLID:11000955 | Exosome | Glioblastoma cells | 19011622 |
| RLID:11000956 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11000957 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000958 | Exosome | Breast milk | 22211110 |
| RLID:11000960 | Exosome | Plasma | 23663360 |
| RLID:11000961 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000962 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
| RLID:11000963 | Exosome | Serum | 25349172 |
| RLID:11000964 | Extracellular Vesicle | Plasma | 28588009 |
| RLID:11000965 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11000966 | Microvesicle | Glioblastoma cells | 19011622 |
| RLID:11000967 | Microvesicle | Plasma | 23077538 |
| RLID:11000968 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11000969 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000028 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000292 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-93-5p | Splenic marginal zone lymphoma | MNDR-E-MI-71712 |
| MNDR | hsa-miR-93-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-71713 |
| MNDR | hsa-miR-93-5p | Oral squamous cell carcinoma | MNDR-E-MI-71714 |
| MNDR | hsa-miR-93-5p | Large cell neuroendocrine cancer | MNDR-E-MI-71715 |
| MNDR | hsa-miR-93-5p | Medulloblastoma | MNDR-E-MI-71716 |
| MNDR | hsa-miR-93-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-71717 |
| MNDR | hsa-miR-93-5p | Ovarian clear cell carcinoma | MNDR-E-MI-71718 |
| MNDR | hsa-miR-93-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-71719 |
| MNDR | hsa-miR-93-5p | Autism spectrum disorder | MNDR-E-MI-71720 |
| MNDR | hsa-miR-93-5p | Lymphoma | MNDR-E-MI-71721 |
| MNDR | hsa-miR-93-5p | Lymphoma non-hodgkin | MNDR-E-MI-71722 |
| MNDR | hsa-miR-93-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-71723 |
| MNDR | hsa-miR-93-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-71724 |
| MNDR | hsa-miR-93-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-71725 |
| MNDR | hsa-miR-93-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-71726 |
| MNDR | hsa-miR-93-5p | Her2-receptor positive breast cancer | MNDR-E-MI-71727 |
| MNDR | hsa-miR-93-5p | Breast cancer luminal | MNDR-E-MI-71728 |
| MNDR | hsa-miR-93-5p | Muscular disease | MNDR-E-MI-71729 |
| MNDR | hsa-miR-93-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-71730 |
| MNDR | hsa-miR-93-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-71731 |
| MNDR | hsa-miR-93-5p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-71732 |
| MNDR | hsa-miR-93-5p | Autosomal recessive limb-girdle muscular dystrophy type 2b | MNDR-E-MI-71733 |
| MNDR | hsa-miR-93-5p | Prostate cancer | MNDR-E-MI-71734 |
| MNDR | hsa-miR-93-5p | Gastric cancer | MNDR-E-MI-71735 |
| MNDR | hsa-miR-93-5p | Gastric lymphoma | MNDR-E-MI-71736 |
| MNDR | hsa-miR-93-5p | Alzheimer disease | MNDR-E-MI-71737 |
| MNDR | hsa-miR-93-5p | Intracranial aneurysm | MNDR-E-MI-71738 |
| MNDR | hsa-miR-93-5p | Bladder cancer | MNDR-E-MI-71739 |
| MNDR | hsa-miR-93-5p | Esophageal carcinoma | MNDR-E-MI-71740 |
| MNDR | hsa-miR-93-5p | Dysautonomia familial | MNDR-E-MI-71741 |
| MNDR | hsa-miR-93-5p | Polycystic ovary syndrome | MNDR-E-MI-71742 |
| MNDR | hsa-miR-93-5p | Head and neck cancer | MNDR-E-MI-71743 |
| MNDR | hsa-miR-93-5p | Leukemia | MNDR-E-MI-71744 |
| MNDR | hsa-miR-93-5p | Leiomyoma | MNDR-E-MI-71745 |
| MNDR | hsa-miR-93-5p | Huntington disease | MNDR-E-MI-71746 |
| MNDR | hsa-miR-93-5p | Chorea | MNDR-E-MI-71747 |
| MNDR | hsa-miR-93-5p | Cardiovascular disease | MNDR-E-MI-71748 |
| MNDR | hsa-miR-93-5p | Carotid stenosis | MNDR-E-MI-71749 |
| MNDR | hsa-miR-93-5p | Lung cancer | MNDR-E-MI-71750 |
| MNDR | hsa-miR-93-5p | Endometrial cancer | MNDR-E-MI-71751 |
| MNDR | hsa-miR-93-5p | Down syndrome | MNDR-E-MI-71752 |
| MNDR | hsa-miR-93-5p | Fragile x syndrome | MNDR-E-MI-71753 |
| MNDR | hsa-miR-93-5p | Parkinson disease | MNDR-E-MI-71754 |
| MNDR | hsa-miR-93-5p | Basal-like breast cancer | MNDR-E-MI-71755 |
| MNDR | hsa-miR-93-5p | Cancer | MNDR-E-MI-71756 |
| MNDR | hsa-miR-93-5p | Squamous cell carcinoma | MNDR-E-MI-71757 |
| MNDR | hsa-miR-93-5p | Thyroid cancer | MNDR-E-MI-71758 |
| MNDR | hsa-miR-93-5p | Pituitary neoplasms | MNDR-E-MI-71759 |
| MNDR | hsa-miR-93-5p | Pancreatic cancer | MNDR-E-MI-71760 |
| MNDR | hsa-miR-93-5p | Melanoma | MNDR-E-MI-71761 |
| MNDR | hsa-miR-93-5p | Lesch-nyhan syndrome | MNDR-E-MI-71762 |
| MNDR | hsa-miR-93-5p | Nephroblastoma | MNDR-E-MI-71763 |
| MNDR | hsa-miR-93-5p | Colon cancer | MNDR-E-MI-71764 |
| MNDR | hsa-miR-93-5p | Ischemic attack transient | MNDR-E-MI-71765 |
| MNDR | hsa-miR-93-5p | Syndrome | MNDR-E-MI-71766 |
| MNDR | hsa-miR-93-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-71767 |
| MNDR | hsa-miR-93-5p | Familial ovarian cancer | MNDR-E-MI-71768 |
| MNDR | hsa-miR-93-5p | Prostate adenocarcinoma | MNDR-E-MI-71769 |
| MNDR | hsa-miR-93-5p | Laryngeal neoplasms | MNDR-E-MI-71770 |
| MNDR | hsa-miR-93-5p | Kidney cancer | MNDR-E-MI-71771 |
| MNDR | hsa-miR-93-5p | Endometrial carcinoma | MNDR-E-MI-71772 |
| MNDR | hsa-miR-93-5p | Laryngeal squamous cell carcinoma | MNDR-E-MI-71773 |
| MNDR | hsa-miR-93-5p | Pulmonary tuberculosis | MNDR-E-MI-71774 |
| MNDR | hsa-miR-93-5p | Adenocarcinoma | MNDR-E-MI-71775 |
| MNDR | hsa-miR-93-5p | Carcinoma ductal breast | MNDR-E-MI-71776 |
| MNDR | hsa-miR-93-5p | Glioblastoma | MNDR-E-MI-71777 |
| MNDR | hsa-miR-93-5p | Astrocytoma | MNDR-E-MI-71778 |
| MNDR | hsa-miR-93-5p | Glioma | MNDR-E-MI-71779 |
| MNDR | hsa-miR-93-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-71780 |
| MNDR | hsa-miR-93-5p | Nemaline myopathy | MNDR-E-MI-71781 |
| MNDR | hsa-miR-93-5p | Neurilemmoma | MNDR-E-MI-71782 |
| MNDR | hsa-miR-93-5p | Chordoma | MNDR-E-MI-71783 |
| MNDR | hsa-miR-93-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-71784 |
| MNDR | hsa-miR-93-5p | Osteosarcoma | MNDR-E-MI-71785 |
| MNDR | hsa-miR-93-5p | Coronary artery disease | MNDR-E-MI-71786 |
| MNDR | hsa-miR-93-5p | Breast carcinoma | MNDR-E-MI-71787 |
| MNDR | hsa-miR-93-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-71788 |
| MNDR | hsa-miR-93-5p | Liver cancer | MNDR-E-MI-71789 |
| MNDR | hsa-miR-93-5p | Uterine cancer | MNDR-E-MI-71790 |
| MNDR | hsa-miR-93-5p | Cervical adenocarcinoma | MNDR-E-MI-71791 |
| MNDR | hsa-miR-93-5p | Gastric adenocarcinoma | MNDR-E-MI-71792 |
| MNDR | hsa-miR-93-5p | Cervical squamous cell carcinoma | MNDR-E-MI-71793 |
| MNDR | hsa-miR-93-5p | Pituitary adenoma | MNDR-E-MI-71794 |
| MNDR | hsa-miR-93-5p | Lung squamous cell carcinoma | MNDR-E-MI-71795 |
| MNDR | hsa-miR-93-5p | Carcinoma lung non-small-cell | MNDR-E-MI-71796 |
| MNDR | hsa-miR-93-5p | Lung adenocarcinoma | MNDR-E-MI-71797 |
| MNDR | hsa-miR-93-5p | Ovarian carcinoma | MNDR-E-MI-71798 |
| MNDR | hsa-miR-93-5p | Bladder urothelial carcinoma | MNDR-E-MI-71799 |
| MNDR | hsa-miR-93-5p | Pancreatic adenocarcinoma | MNDR-E-MI-71800 |
| MNDR | hsa-miR-93-5p | Brain stem cancer | MNDR-E-MI-71801 |
| MNDR | hsa-miR-93-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-71802 |
| MNDR | hsa-miR-93-5p | Carcinoma renal cell | MNDR-E-MI-71803 |
| MNDR | hsa-miR-93-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-71804 |
| MNDR | hsa-miR-93-5p | Clear cell renal cell carcinoma | MNDR-E-MI-71805 |
| MNDR | hsa-miR-93-5p | Biliary tract cancer | MNDR-E-MI-71806 |
| MNDR | hsa-miR-93-5p | Esophageal adenocarcinoma | MNDR-E-MI-71807 |
| MNDR | hsa-miR-93-5p | Cholangiocarcinoma | MNDR-E-MI-71808 |
| MNDR | hsa-miR-93-5p | Esophageal cancer | MNDR-E-MI-71809 |
| MNDR | hsa-miR-93-5p | Liver cirrhosis | MNDR-E-MI-71810 |
| MNDR | hsa-miR-93-5p | Prolactinoma | MNDR-E-MI-71811 |
| MNDR | hsa-miR-93-5p | Lung small cell carcinoma | MNDR-E-MI-71812 |
| MNDR | hsa-miR-93-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-71813 |
| MNDR | hsa-miR-93-5p | T acute lymphoblastic leukemia | MNDR-E-MI-71814 |
| MNDR | hsa-miR-93-5p | Acute t cell leukemia | MNDR-E-MI-71815 |
| MNDR | hsa-miR-93-5p | Heart failure | MNDR-E-MI-71816 |
| MNDR | hsa-miR-93-5p | Breast invasive carcinoma | MNDR-E-MI-71817 |
| MNDR | hsa-miR-93-5p | Early hepatocellular carcinoma | MNDR-E-MI-71818 |
| MNDR | hsa-miR-93-5p | Familiar ovarian carcinoma | MNDR-E-MI-71819 |
| MNDR | hsa-miR-93-5p | B-cell lymphoma | MNDR-E-MI-71820 |
| MNDR | hsa-miR-93-5p | Rheumatoid arthritis | MNDR-E-MI-71821 |
| MNDR | hsa-miR-93-5p | T-cell leukemia | MNDR-E-MI-71822 |
| MNDR | hsa-miR-93-5p | Neuroblastoma | MNDR-E-MI-71823 |
| MNDR | hsa-miR-93-5p | Chronic kidney disease | MNDR-E-MI-71824 |
| MNDR | hsa-miR-93-5p | Hodgkin disease | MNDR-E-MI-71825 |
| MNDR | hsa-miR-93-5p | Burkitt lymphoma | MNDR-E-MI-71826 |
| MNDR | hsa-miR-93-5p | Mycosis fungoides | MNDR-E-MI-71827 |
| MNDR | hsa-miR-93-5p | Dementia vascular | MNDR-E-MI-71828 |
| MNDR | hsa-miR-93-5p | Tonsil cancer | MNDR-E-MI-71829 |
| MNDR | hsa-miR-93-5p | Neuromyelitis optica | MNDR-E-MI-71830 |
| MNDR | hsa-miR-93-5p | Degenerative disc disease | MNDR-E-MI-71831 |
| MNDR | hsa-miR-93-5p | Acute myelocytic leukemia | MNDR-E-MI-71832 |
| MNDR | hsa-miR-93-5p | Colorectal cancer | MNDR-E-MI-71833 |
| MNDR | hsa-miR-93-5p | Nasopharynx carcinoma | MNDR-E-MI-71834 |
| MNDR | hsa-miR-93-5p | Multiple myeloma | MNDR-E-MI-71835 |
| MNDR | hsa-miR-93-5p | Acute lymphocytic leukemia | MNDR-E-MI-71836 |
| MNDR | hsa-miR-93-5p | Toxoplasmosis | MNDR-E-MI-71837 |
| MNDR | hsa-miR-93-5p | Brain injuries traumatic | MNDR-E-MI-71838 |
| MNDR | hsa-miR-93-5p | Ovarian epithelial cancer | MNDR-E-MI-71839 |
| MNDR | hsa-miR-93-5p | Ependymoma | MNDR-E-MI-71840 |
| MNDR | hsa-miR-93-5p | Nasopharyngeal cancer | MNDR-E-MI-71841 |
| MNDR | hsa-miR-93-5p | Prostatic neoplasms | MNDR-E-MI-71842 |
| MNDR | hsa-miR-93-5p | Trophoblasts | MNDR-E-MI-71843 |
| MNDR | hsa-miR-93-5p | Vesicular stomatitis | MNDR-E-MI-71844 |
| MNDR | hsa-miR-93-5p | Stroke lacunar | MNDR-E-MI-71845 |
| MNDR | hsa-miR-93-5p | Breast cancer her3+ negative | MNDR-E-MI-71846 |
| MNDR | hsa-miR-93-5p | Duke C | MNDR-E-MI-71847 |
| MNDR | hsa-miR-93-5p | High grade dysplastic nodule | MNDR-E-MI-71848 |
| MNDR | hsa-miR-93-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-71849 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCA1 | Homo sapiens | RR00022148 |
TOP